NASDAQ:VNDA

Vanda Pharmaceuticals Stock Insider Trading

etoro logo Buy VNDA
*Your capital is at risk
$5.95
-0.0500 (-0.83%)
At Close: Jun 23, 2026

Vanda Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -8.38. In total, the insiders bought 4.01M and sold 768.86K VNDA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-8.38
Buy 4.01M shares
Sell 768.86K shares
81% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Mar 02, 2026

Analysis Breakdown:

  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 04, 2026
Buy
Common Stock
Mcguire Daniel Patrick
SVP, GC And Secretary
Officer 0
Value: $0
Jun 04, 2026
Buy
Common Stock
A-Award
Mitchell Stephen Ray
Director
Director 41 600
Value: $260.0K
Jun 04, 2026
Buy
Common Stock
A-Award
Ward Anne Sempowski
Director
Director 41 600
Value: $260.0K
Jun 04, 2026
Buy
Common Stock
A-Award
Dugan Richard W
Director
Director 41 600
Value: $260.0K
Jun 04, 2026
Buy
Common Stock
A-Award
Mcguire Daniel Patrick
SVP, GC And Secretary
Officer 80 000
Value: $500.0K
Jun 04, 2026
Buy
Common Stock
A-Award
Chrousos Phaedra
Director
Director 41 600
Value: $260.0K
Jun 04, 2026
Buy
Common Stock
A-Award
Duncan Charles Cliff
Director
Director 41 600
Value: $260.0K
Jun 04, 2026
Buy
Common Stock
A-Award
Honore Tage
Director
Director 41 600
Value: $260.0K
Jun 04, 2026
Buy
Common Stock
Mcguire Daniel Patrick
SVP, GC And Secretary
Officer 0
Value: $0
Jun 04, 2026
Buy
Common Stock
Mcguire Daniel Patrick
SVP, GC And Secretary
Officer 0
Value: $0
Jun 04, 2026
Buy
Common Stock
Mcguire Daniel Patrick
SVP, GC And Secretary
Officer 0
Value: $0
May 18, 2026
Sell
Common Stock
G-Gift
Mitchell Stephen Ray
Director
Director 25 836
Value: $0
Apr 22, 2026
Buy
Common Stock
A-Award
Duncan Charles Cliff
Director
Director 57 101
Value: $390.0K
Apr 22, 2026
Buy
Common Stock
J-Other
Duncan Charles Cliff
Insider
Other 0
Value: $0
Apr 01, 2026
Buy
Stock Option (Right to Buy)
Howell Scott Laverne
Vp And Chief People Officer
Officer 25 000
Value: $283.0K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
Howell Scott Laverne
Vp And Chief People Officer
Officer 28 600
Value: $580.0K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
Howell Scott Laverne
Vp And Chief People Officer
Officer 61 200
Value: $695.2K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
Howell Scott Laverne
Vp And Chief People Officer
Officer 77 500
Value: $546.4K
Apr 01, 2026
Buy
Common Stock
Howell Scott Laverne
Vp And Chief People Officer
Officer 0
Value: $0
Apr 01, 2026
Buy
Common Stock
Howell Scott Laverne
Vp And Chief People Officer
Officer 0
Value: $0
Apr 01, 2026
Buy
Common Stock
Howell Scott Laverne
Vp And Chief People Officer
Officer 0
Value: $0
Apr 01, 2026
Buy
Common Stock
Polymeropoulos Christos Vasilios Mihael
Senior Vp, Medical Director
Officer 0
Value: $0
Apr 01, 2026
Buy
Common Stock
Polymeropoulos Christos Vasilios Mihael
Senior Vp, Medical Director
Officer 0
Value: $0
Apr 01, 2026
Buy
Common Stock
Polymeropoulos Christos Vasilios Mihael
Senior Vp, Medical Director
Officer 0
Value: $0
Apr 01, 2026
Buy
Common Stock
Polymeropoulos Christos Vasilios Mihael
Senior Vp, Medical Director
Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VANDA PHARMACEUTICALS INC.
Vanda Pharmaceuticals
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatr...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE